Pedro Luis
Sánchez Fernández
Catedrático de Universidad
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro Nacional de Investigaciones Cardiovasculares Carlos III (11)
2024
2023
2022
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2021
-
Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity
Cardiovascular research, Vol. 117, Núm. 4, pp. 1132-1143
2020
-
Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy
Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 268-269
2019
-
Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity
Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791
2017
-
Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage
Circulation, Vol. 136, Núm. 14, pp. 1288-1300
-
Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition after Myocardial Infarction
Circulation Research, Vol. 121, Núm. 4, pp. 439-450
2016
-
Data from acellular human heart matrix
Data in Brief
2015
-
Acellular human heart matrix: A critical step toward whole heart grafts
Biomaterials, Vol. 61, pp. 279-289